Skip to main content
Top

Drugs

Issue 6/2008

Content (9 Articles)

Therapy for Helicobacter pylori Infection Can be Improved

  • Current Opinion

David Y. Graham, Hong Lu, Yoshio Yamaoka

Bevacizumab in Non-Small Cell Lung Cancer

  • Leading Article

Francesco Di Costanzo, Francesca Mazzoni, Marinella Micol Mela, Lorenzo Antonuzzo, Daniele Checcacci, Matilde Saggese, Federica Di Costanzo

Pharmaceutical Management of Ovarian Cancer

  • Review Article

Maurie Markman

Early and Sustained Virological Response in Non-Responders with Chronic Hepatitis C

  • Original Research Article

Gaetano Scotto, Vincenzina Fazio, Chiara Fornabaio, Alessandra Tartaglia, Rocco Di Tullio, Annalisa Saracino, Gioacchino Angarano

Meropenem

  • Adis Drug Evaluation

Claudine M. Baldwin, Katherine A. Lyseng-Williamson, Susan J. Keam

Sucrose-Formulated Octocog Alfa

  • Adis Drug Evaluation

James E. Frampton, Antona J. Wagstaff

Retapamulin

  • Adis Drug Evaluation

Lily P. H. Yang, Susan J. Keam

Ciclesonide Nasal Spray

  • Adis Drug Profile

Sohita Dhillon, Antona J. Wagstaff

Keynote webinar | Spotlight on dry eye disease

  • Live
  • Webinar | 28-05-2026 | 13:00 (CEST)

DED is highly prevalent yet challenging to diagnose and treat. Join leading experts to explore the latest developments and gain practical guidance on effective management in busy clinical settings. Brought to you by Springer Medicine and Eye.

Watch it live: 28 May 2026, 13:00–14:00 (CEST)

Prof. Harminder Dua
Prof. Sajjad Ahmad
Prof. Anat Galor
Join the webinar
Webinar
Image Credits
Conceptual illustration of dry eye disease/© Science Photo Library / Getty Images